Reduced baseline sensitivity to Maraviroc inhibition among R5 HIV-1 isolates from individuals with severe immunodeficiency.

Ulf Karlsson; Johanna Repits; Liselotte Antonsson; Erik Cederfjäll; Bengt Ljungberg; Martin Ålenius; Alan Sabirsh; Magnus Gisslen; Joakim Esbjörnsson; Marianne Jansson

doi:10.1097/QAI.0000000000000873

Reduced baseline sensitivity to Maraviroc inhibition among R5 HIV-1 isolates from individuals with severe immunodeficiency.

Ulf Karlsson, Johanna Repits, Liselotte Antonsson, Erik Cederfjäll, Bengt Ljungberg, Martin Ålenius, Alan Sabirsh, Magnus Gisslen, Joakim Esbjörnsson, Marianne Jansson

Forskningsoutput: Tidskriftsbidrag › Letter › Peer review

Originalspråk	engelska
Tidskrift	Journal of Acquired Immune Deficiency Syndromes
Volym	71
Nummer	3
Tidigt onlinedatum	2015 okt. 21
DOI	https://doi.org/10.1097/QAI.0000000000000873
Status	Published - 2016

Bibliografisk information

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Clinical Virology, Malmö (013017580), Faculty of Medicine (000022000), Department of Experimental Medical Science (013210000), Division of Medical Microbiology (013250400), Division of Infection Medicine (SUS) (013008000), Brain Repair and Imaging in Neural Systems (BRAINS) (013212027), Drug Target Discovery (013212045)

Ämnesklassifikation (UKÄ)

Infektionsmedicin

FN:s Globala mål

Denna forskningsoutput relaterar till följande Globala mål

Tillgång till dokument

10.1097/QAI.0000000000000873

http://www.ncbi.nlm.nih.gov/pubmed/26492461?dopt=Abstract

Citera det här

Karlsson, U., Repits, J., Antonsson, L., Cederfjäll, E., Ljungberg, B., Ålenius, M., Sabirsh, A., Gisslen, M., Esbjörnsson, J., & Jansson, M. (2016). Reduced baseline sensitivity to Maraviroc inhibition among R5 HIV-1 isolates from individuals with severe immunodeficiency. Journal of Acquired Immune Deficiency Syndromes, 71(3). https://doi.org/10.1097/QAI.0000000000000873

@article{0b002b4993304a1b92ec1b61f91d7295,

title = "Reduced baseline sensitivity to Maraviroc inhibition among R5 HIV-1 isolates from individuals with severe immunodeficiency.",

author = "Ulf Karlsson and Johanna Repits and Liselotte Antonsson and Erik Cederfj{\"a}ll and Bengt Ljungberg and Martin {\AA}lenius and Alan Sabirsh and Magnus Gisslen and Joakim Esbj{\"o}rnsson and Marianne Jansson",

note = "The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Clinical Virology, Malm{\"o} (013017580), Faculty of Medicine (000022000), Department of Experimental Medical Science (013210000), Division of Medical Microbiology (013250400), Division of Infection Medicine (SUS) (013008000), Brain Repair and Imaging in Neural Systems (BRAINS) (013212027), Drug Target Discovery (013212045)",

year = "2016",

doi = "10.1097/QAI.0000000000000873",

language = "English",

volume = "71",

journal = "Journal of Acquired Immune Deficiency Syndromes",

issn = "1525-4135",

publisher = "Wolters Kluwer Health",

number = "3",

}

Karlsson, U, Repits, J, Antonsson, L, Cederfjäll, E, Ljungberg, B, Ålenius, M, Sabirsh, A, Gisslen, M, Esbjörnsson, J & Jansson, M 2016, 'Reduced baseline sensitivity to Maraviroc inhibition among R5 HIV-1 isolates from individuals with severe immunodeficiency.', Journal of Acquired Immune Deficiency Syndromes, vol. 71, nr. 3. https://doi.org/10.1097/QAI.0000000000000873

TY - JOUR

T1 - Reduced baseline sensitivity to Maraviroc inhibition among R5 HIV-1 isolates from individuals with severe immunodeficiency.

AU - Karlsson, Ulf

AU - Repits, Johanna

AU - Antonsson, Liselotte

AU - Cederfjäll, Erik

AU - Ljungberg, Bengt

AU - Ålenius, Martin

AU - Sabirsh, Alan

AU - Gisslen, Magnus

AU - Esbjörnsson, Joakim

AU - Jansson, Marianne

N1 - The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Clinical Virology, Malmö (013017580), Faculty of Medicine (000022000), Department of Experimental Medical Science (013210000), Division of Medical Microbiology (013250400), Division of Infection Medicine (SUS) (013008000), Brain Repair and Imaging in Neural Systems (BRAINS) (013212027), Drug Target Discovery (013212045)

PY - 2016

Y1 - 2016

U2 - 10.1097/QAI.0000000000000873

DO - 10.1097/QAI.0000000000000873

M3 - Letter

C2 - 26492461

SN - 1525-4135

VL - 71

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

IS - 3

ER -